Sexual Dysfunction in Patients With Myofascial Pain Syndrome

May 12, 2025 updated by: Ramazan Yılmaz, MD, Konya Beyhekim Training and Research Hospital
This study evaluates the frequency of sexual dysfunction in women with myofascial pain syndrome and its relationship with clinical parameters.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The frequency of sexual dysfunction in reproductive-aged married women with primary myofascial pain syndrome will be evaluated in a prospective, cross-sectional survey-type study. The medical history of each participant was obtained and they underwent a detailed physical examination. Sociodemographic and clinic characteristics of all participants (age, education, marital status, employment status, family structure, income status, Body Mass Index(BMI), disease duration, number of pregnancies, sleep quality, etc.) were recorded. Pain and fatigue levels of the patients were measured by the visual pain scale (VAS), mood states by the Beck depression index (BDI), sexual function of the participants was assessed by the 0-10 Visual Analog Scale (VAS) to assess the degree of importance of sexuality (the sexuality-importance score). In addition, weekly/monthly sexual intercourse frequency was asked to all participants (patient and control groups). The questionnaires were administered to all participants in a room where they were alone with a female physician, and a suitable environment was provided for the patients to fill out the questionnaire. Patients were assured of the confidentiality of their information. Only questions that were not understood by the patient were explained without guidance.

Study Type

Observational

Enrollment (Actual)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Konya, Turkey, 42060
        • University of Health Sciences, Konya Beyhekim Training and Research Hospital, Department of Physical Medicine and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

40 patients with primer myofascial pain syndrome and 40 healthy volunteers

Description

Inclusion Criteria:

  • Myofascial pain syndrome (>3 months) was diagnosed in a female.
  • Being between the ages of 18 and 50, married, sexually active, and not menopausal
  • Volunteering to participate in the study, and being able to communicate easily.

Exclusion Criteria:

  • a history of systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological, etc.)
  • major psychiatric illness, mental retardation
  • uncontrollable respiratory system problems
  • endocrine diseases, neurological diseases
  • previous hysterectomy or vaginal surgery, a history of sexually transmitted diseases
  • urinary or anal incontinence
  • limited motion in the upper or lower extremities
  • Fibromyalgia
  • inflammatory rheumatic diseases (such as rheumatoid arthritis, ankylosing spondylitis, etc.)
  • cervical/lumbar radiculopathy or myelopathy
  • communication problems
  • pregnancy, lactation
  • taking estrogen therapy
  • use antidepressant, anxiolytic, and antiepileptic drugs
  • chronic alcohol users

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with primer myofascial pain sydrome
pain for at least three months (myofascial pain) reproductive-aged married womens (18-50 years)
Other: visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency
visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency
Healthy controls
Healthy control of reproductive-aged married women with compatible sociodemographic characteristics
Other: visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency
visual pain scale (VASpain/fatigue), Beck depression index (BDI), the sexuality-importance score, sexual intercourse frequency

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sexuality-importance score
Time Frame: 11.05.2022-15.03.2023 (cross-sectional)
Sexual function of the participants was assessed by the 0 (never mind)-10(very important) Visual Analog Scale (VAS) to assess the degree of importance of sexuality.
11.05.2022-15.03.2023 (cross-sectional)
The frequency of sexual intercourse
Time Frame: 11.05.2022-15.03.2023 (cross-sectional
Weekly/monthly sexual intercourse frequency was asked of all participants.
11.05.2022-15.03.2023 (cross-sectional

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual analog scale (VAS pain/fatigue)
Time Frame: 11.05.2022 - 15.03.2023 (cross-sectional)
All participants were assessed in terms of pain and fatigue levels by means of a visual analogue scale of 0-10 cm (VAS).
11.05.2022 - 15.03.2023 (cross-sectional)
Beck depression index (BDI)
Time Frame: 11.05.2022 - 15.03.2023 (cross-sectional)
In the assessment of depression severity, the Turkish version of the 21-item Beck Depression Inventory (BDI) was used, which is one of the most common psychometric tests used and a value of 0 to 3 is assigned for each answer to each item.
11.05.2022 - 15.03.2023 (cross-sectional)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Konya Beyhekim Training and Research Hospital

Investigators

  • Study Chair: Ramazan Yılmaz, asist. prof, Konya Beyhekim Training and Research Hospital, Konya, Turkey

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 11, 2022

Primary Completion (Actual)

March 15, 2023

Study Completion (Actual)

April 15, 2023

Study Registration Dates

First Submitted

February 5, 2023

First Submitted That Met QC Criteria

February 5, 2023

First Posted (Actual)

February 14, 2023

Study Record Updates

Last Update Posted (Actual)

May 13, 2025

Last Update Submitted That Met QC Criteria

May 12, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KonyaBeyhekimTRH2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe